Absence of an interaction between the angiotensinconverting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: The Genetics of Hypertension-Associated Treatment (GenHAT) study
Publication date
2007
Authors
Maitland-van der Zee, Anke Hilse
Boerwinkle, E.
Arnett, D.K.
Davis, B.R.
Leiendecker-Foster, C.
Miller, M.B.
Klungel, Olaf H.
Ford, C.E.
Eckfeldt, J.H.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, SDG 3 - Good Health and Well-being
Citation
Maitland-van der Zee, A H, Boerwinkle, E, Arnett, D K, Davis, B R, Leiendecker-Foster, C, Miller, M B, Klungel, O H, Ford, C E & Eckfeldt, J H 2007, 'Absence of an interaction between the angiotensinconverting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: The Genetics of Hypertension-Associated Treatment (GenHAT) study', American Heart Journal, vol. 153, pp. 54-58.